COVID-19 Response Fund Boosts SMHS Research Efforts

It’s hard to recall a more important time for groundbreaking scientific research when it comes to the health and safety of the United States than in the past six months; by October the country had recorded more than 7 million cases of the novel coronavirus, and the global toll passed 1 million fatalities. 

Latest News

We are thrilled to announce that The Chang Lab is currently enrolling participants for our groundbreaking clinical trials being conducted in Barranquilla, Colombia! This marks a significant step forward in our translational research efforts.
In 2020, Cures Within Reach funded Dr. Aileen Chang at George Washington University to support a Phase I trial evaluating the safety and efficacy of an approved flu drug, zanamivir, for patients with severe dengue infections in Colombia.
Dengue viruses (DenV) are among the leading causes of pediatric morbidity and mortality globally, with 96 million symptomatic cases annually worldwide and no targeted treatments.